NYSE:MET - Metlife Stock Price, News & Analysis

$45.35
+0.62 (+1.39 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
$44.49
Now: $45.35
$45.65
50-Day Range
$44.94
MA: $49.07
$50.92
52-Week Range
$37.76
Now: $45.35
$51.16
Volume7.14 million shs
Average Volume6.00 million shs
Market Capitalization$42.47 billion
P/E Ratio8.41
Dividend Yield3.92%
Beta1.09
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements. Read More…

Industry, Sector and Symbol

Industry Life insurance
Sub-IndustryLife & Health Insurance
SectorFinance
CUSIP59156R10
Phone212-578-9500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$67.94 billion
Cash Flow$5.2007 per share
Book Value$68.39 per share

Profitability

Net Income$5.12 billion

Miscellaneous

Employees48,000
Market Cap$42.47 billion
Next Earnings Date11/7/2019 (Estimated)
OptionableOptionable

Receive MET News and Ratings via Email

Sign-up to receive the latest news and ratings for MET and its competitors with MarketBeat's FREE daily newsletter.


Metlife (NYSE:MET) Frequently Asked Questions

What is Metlife's stock symbol?

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

How often does Metlife pay dividends? What is the dividend yield for Metlife?

Metlife declared a quarterly dividend on Monday, July 8th. Stockholders of record on Tuesday, August 6th will be paid a dividend of $0.44 per share on Friday, September 13th. This represents a $1.76 annualized dividend and a dividend yield of 3.88%. The ex-dividend date is Monday, August 5th. View Metlife's Dividend History.

How will Metlife's stock buyback program work?

Metlife declared that its Board of Directors has initiated a stock buyback plan on Thursday, November 1st 2018, which authorizes the company to repurchase $2,000,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 4.6% of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board believes its stock is undervalued.

How were Metlife's earnings last quarter?

Metlife Inc (NYSE:MET) announced its quarterly earnings data on Wednesday, July, 31st. The financial services provider reported $1.38 earnings per share for the quarter, topping the consensus estimate of $1.31 by $0.07. The financial services provider earned $16.45 billion during the quarter, compared to the consensus estimate of $16.43 billion. Metlife had a return on equity of 9.75% and a net margin of 9.28%. The company's revenue was down 22.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.30 earnings per share. View Metlife's Earnings History.

When is Metlife's next earnings date?

Metlife is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Metlife.

What price target have analysts set for MET?

11 equities research analysts have issued twelve-month price objectives for Metlife's shares. Their forecasts range from $42.00 to $63.00. On average, they expect Metlife's share price to reach $50.9060 in the next year. This suggests a possible upside of 12.3% from the stock's current price. View Analyst Price Targets for Metlife.

What is the consensus analysts' recommendation for Metlife?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 1 sell rating, 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Metlife.

What are Wall Street analysts saying about Metlife stock?

Here are some recent quotes from research analysts about Metlife stock:
  • 1. According to Zacks Investment Research, "MetLife’s earnings of $1.38 per share beat the Zacks Consensus Estimate by 5.34%, and were up 6.2% year over year, on the back of lower expenses, partly offset by decline in revenues. Shares of the company have outperformed its industry, year to date. It has been performing well led by prudent underwriting and expense management. Its efforts to streamline business and focus on core operations are impressive. The company’s revenue base has been growing and the trend is likely to continue. Its disciplined capital deployment is expected to drive long-term growth. However, its exposure to cat loss remains a concern. Investment in efficiency programs will put pressure on margins. Also, the company's declining net investment income might continue to suffer in 2019 due to low investment yields." (8/2/2019)
  • 2. Wells Fargo & Co analysts commented, "We do not expect much movement in the shares after our meetings. Our EPS estimates and price target are unchanged. We continue to have an Outperform rating on the shares." (6/5/2019)

Has Metlife been receiving favorable news coverage?

News stories about MET stock have trended negative recently, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Metlife earned a news sentiment score of -2.3 on InfoTrie's scale. They also assigned news stories about the financial services provider a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Metlife.

Are investors shorting Metlife?

Metlife saw a decline in short interest during the month of July. As of July 31st, there was short interest totalling 9,173,300 shares, a decline of 8.9% from the June 30th total of 10,067,600 shares. Based on an average daily volume of 4,600,000 shares, the days-to-cover ratio is presently 2.0 days. Currently, 1.1% of the shares of the company are sold short. View Metlife's Current Options Chain.

Who are some of Metlife's key competitors?

What other stocks do shareholders of Metlife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Metlife investors own include General Electric (GE), AT&T (T), Bank of America (BAC), IBM (IBM), Intel (INTC), Exxon Mobil (XOM), Gilead Sciences (GILD), Pfizer (PFE), Verizon Communications (VZ) and Cisco Systems (CSCO).

Who are Metlife's key executives?

Metlife's management team includes the folowing people:
  • Mr. Michel A. Khalaf, CEO, Pres & Director (Age 55)
  • Mr. John Dennis McCallion CPA, Exec. VP & CFO (Age 45)
  • Mr. Steven Jeffrey Goulart, Exec. VP & Chief Investment Officer (Age 60)
  • Ms. Tamara L. Schock C.A., CPA, Exec. VP & Chief Accounting Officer (Age 47)
  • Mr. John Arthur Hall, Sr. VP & Head of Investor Relations

Who are Metlife's major shareholders?

Metlife's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.78%), Vanguard Group Inc. (7.20%), Price T Rowe Associates Inc. MD (2.02%), Bank of New York Mellon Corp (1.50%), Northern Trust Corp (1.22%) and Diamond Hill Capital Management Inc. (1.05%). Company insiders that own Metlife stock include Carlos M Gutierrez, Christopher G Townsend, Gerald L Hassell, John D Mccallion, Steven A Kandarian and Steven J Goulart. View Institutional Ownership Trends for Metlife.

Which major investors are selling Metlife stock?

MET stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Diamond Hill Capital Management Inc., Bank of New York Mellon Corp, Bank of Montreal Can, DekaBank Deutsche Girozentrale, AGF Investments Inc., Nuance Investments LLC and California Public Employees Retirement System. Company insiders that have sold Metlife company stock in the last year include John D Mccallion, Steven A Kandarian and Steven J Goulart. View Insider Buying and Selling for Metlife.

Which major investors are buying Metlife stock?

MET stock was bought by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, AQR Capital Management LLC, BlackRock Inc., Panagora Asset Management Inc., Charles Schwab Investment Management Inc., Vanguard Group Inc., Clark Capital Management Group Inc. and Price T Rowe Associates Inc. MD. Company insiders that have bought Metlife stock in the last two years include Carlos M Gutierrez and Gerald L Hassell. View Insider Buying and Selling for Metlife.

How do I buy shares of Metlife?

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Metlife's stock price today?

One share of MET stock can currently be purchased for approximately $45.35.

How big of a company is Metlife?

Metlife has a market capitalization of $42.47 billion and generates $67.94 billion in revenue each year. The financial services provider earns $5.12 billion in net income (profit) each year or $5.39 on an earnings per share basis. Metlife employs 48,000 workers across the globe.View Additional Information About Metlife.

What is Metlife's official website?

The official website for Metlife is http://www.metlife.com/.

How can I contact Metlife?

Metlife's mailing address is 200 PARK AVENUE, NEW YORK NY, 10166. The financial services provider can be reached via phone at 212-578-9500.


MarketBeat Community Rating for Metlife (NYSE MET)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  794 (Vote Outperform)
Underperform Votes:  518 (Vote Underperform)
Total Votes:  1,312
MarketBeat's community ratings are surveys of what our community members think about Metlife and other stocks. Vote "Outperform" if you believe MET will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MET will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel